Home » Stocks » ZYXI

Zynex, Inc. (ZYXI)

Stock Price: $14.25 USD -0.44 (-3.00%)
Updated Mar 2, 2021 4:00 PM EST - Market closed
Market Cap 495.71M
Revenue (ttm) 80.12M
Net Income (ttm) 9.07M
Shares Out 33.87M
EPS (ttm) 0.26
PE Ratio 54.81
Forward PE 46.95
Dividend n/a
Dividend Yield n/a
Trading Day March 2
Last Price $14.25
Previous Close $14.69
Change ($) -0.44
Change (%) -3.00%
Day's Open 14.74
Day's Range 14.21 - 14.93
Day's Volume 884,424
52-Week Range 7.93 - 29.73

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
24/7 Wall Street - 4 days ago

With the trading day more than halfway over, the broad markets recovered slightly from Thursday's downturn, with the exception of the Dow Jones industrial average.

Other stocks mentioned: ABNB, EDIT, CNP, AGIO, DNLI, PTR, TREE, VYGR
The Motley Fool - 4 days ago

Investors are reacting negatively to the company's Q4 results and Q1 outlook.

Benzinga - 5 days ago

Shares of Zynex (NASDAQ:ZYXI) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 44.44% over the past year to $0.05, which misse...

PRNewsWire - 5 days ago

ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted...

PRNewsWire - 1 week ago

ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

PRNewsWire - 1 month ago

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

PRNewsWire - 1 month ago

ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

PRNewsWire - 1 month ago

ENGLEWOOD, Colo., Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

The Motley Fool - 1 month ago

These three small-cap stocks all turned a profit last quarter and present ample growth potential at bargain prices.

Other stocks mentioned: KOP, RGNX
PRNewsWire - 3 months ago

ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

PRNewsWire - 3 months ago

ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

Seeking Alpha - 4 months ago

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q3 2020 Results - Earnings Call Transcript

Benzinga - 4 months ago

Shares of Zynex (NASDAQ:ZYXI) decreased 2.79% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to $0.04, which mis...

PRNewsWire - 4 months ago

ENGLEWOOD, Colo., Oct. 27, 2020 /PRNewswire/ -- Revenue increased 69% year over year to $20.0 million Orders increased 96% Net income of $1.3 million; Diluted EPS $0.04 Adjusted EBITDA $2.4 mi...

Seeking Alpha - 4 months ago

Shares have been taken down yet again, on a mild guidance decrease. However, order growth has come back strongly and revenues will follow that.

PRNewsWire - 4 months ago

ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

PRNewsWire - 4 months ago

ENGLEWOOD, Colo., Oct. 20, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices fo...

The Motley Fool - 4 months ago

The medical technology company's revenue isn't growing as much as hoped.

PRNewsWire - 4 months ago

ENGLEWOOD, Co., Oct. 12, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pa...

Seeking Alpha - 4 months ago

Zynex: 'Electric' Growth And Strong Earnings Keep Us Bullish

Investors Business Daily - 5 months ago

A Relative Strength Rating upgrade for Zynex shows improving technical performance. Will it continue?

Investors Business Daily - 6 months ago

A Relative Strength Rating upgrade for Zynex shows improving technical performance. The post Zynex Shows Market Leadership With Jump To 82 RS Rating appeared first on Investor's Business Daily.

The Motley Fool - 6 months ago

These stocks are much cheaper than they were a few months ago and have great long-term prospects.

Other stocks mentioned: MGNI, ROIC
Seeking Alpha - 7 months ago

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q2 2020 Results - Earnings Call Transcript

Benzinga - 7 months ago

Shares of Zynex (NASDAQ:ZYXI) increased 2.65% in after-market trading after the company reported Q2 results.

PRNewsWire - 7 months ago

ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ -- Zynex, Inc.

Zacks Investment Research - 7 months ago

Zynex's (ZYXI) April orders down approximately 35% from the January and February average. This may have impacted its Q2 earnings.

The Motley Fool - 7 months ago

There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.

Other stocks mentioned: IDXX, SMLR
The Motley Fool - 7 months ago

The company announced the pricing of a public offering of common stock.

PRNewsWire - 7 months ago

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical de...

PRNewsWire - 7 months ago

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical de...

The Motley Fool - 7 months ago

The company expects strong second-quarter financial results.

PRNewsWire - 7 months ago

ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for p...

InvestorPlace - 8 months ago

This selection of growth stocks includes some surprise choices and companies set to benefit from the lasting effects of the pandemic.

Other stocks mentioned: ACLS, FORM, LOGI, TNK, VIVO, ZM
The Motley Fool - 8 months ago

Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.

PRNewsWire - 8 months ago

NEW YORK, June 10, 2020 /PRNewswire/ -- Zynex Inc. (NASD:ZYXI) will replace KEMET Corp. (NYSE:KEM) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, June 16. Yageo ...

Seeking Alpha - 9 months ago

How I Find The Right Start-Up To Invest In

Other stocks mentioned: DUOT, OSSIF, SYATF, VQSLF
PRNewsWire - 9 months ago

ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

Zacks Investment Research - 9 months ago

Top Stock Picks for Week of May 11, 2020

Two Medical Products Stocks with Recent Price Strength.

Other stocks mentioned: VIVO
Zacks Investment Research - 9 months ago

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: BDTX, NERV, SPT, THMO
Zacks Investment Research - 9 months ago

Top Ranked Momentum Stocks to Buy for May 5th

Other stocks mentioned: AXGT, GFI, PS
Zacks Investment Research - 9 months ago

An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.

Other stocks mentioned: LMAT, MGNX, QDEL
Investors Business Daily - 10 months ago

Here’s a list of all the top-rated growth stocks that have just been added to the IBD 50, IBD Big Cap 20, Sector Leaders, Stock Spotlight and IPO leaders. The post Medical Device Maker Zynex J...

Seeking Alpha - 10 months ago

Zynex's (ZYXI) CEO Thomas Sandgaard on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

As of late, it has definitely been a great time to be an investor Zynex

Benzinga - 10 months ago

Zynex Inc. (NASDAQ: ZYXI) shares are trading higher on Tuesday, after the company raised its first-quarter and fiscal year 2020 guidance.

Zacks Investment Research - 11 months ago

Zynex has been struggling lately, but the selling pressure may be coming to an end soon.

Seeking Alpha - 11 months ago

Zynex - Growth Comes At A Price

Zacks Investment Research - 1 year ago

Top Ranked Momentum Stocks to Buy for February 28th

Other stocks mentioned: FND, MSCI, WETF
Seeking Alpha - 1 year ago

Zynex's (ZYXI) CEO Thomas Sandgaard on Q4 2019 Results - Earnings Call Transcript

About ZYXI

Zynex, through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and... [Read more...]

Industry
Medical Devices
Founded
1996
CEO
Thomas Sandgaard
Employees
768
Stock Exchange
NASDAQ
Ticker Symbol
ZYXI
Full Company Profile

Financial Performance

In 2020, Zynex's revenue was $80.12 million, an increase of 76.20% compared to the previous year's $45.47 million. Earnings were $9.07 million, a decrease of -4.40%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Zynex stock is "Strong Buy." The 12-month stock price forecast is 24.70, which is an increase of 73.33% from the latest price.

Price Target
$24.70
(73.33% upside)
Analyst Consensus: Strong Buy